{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:32:48Z","timestamp":1787682768831,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"KAKENHI Grant-in-Aid for Exploratory Research","award":["26670399"],"award-info":[{"award-number":["26670399"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jjcc.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T09:01:20Z","timestamp":1481792480000},"page":"278-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity"],"prefix":"10.1016","volume":"70","author":[{"given":"Natsuko","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2016.10.016_bib0155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"Suppl.","key":"10.1016\/j.jjcc.2016.10.016_bib0160","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0167-5273(96)88779-1","article-title":"Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review","volume":"54","author":"Dabague","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005792-198503000-00002","article-title":"Takayasu arteritis. A study of 32 North American patients","volume":"64","author":"Hall","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.57.1.27","article-title":"Natural history and classification of occlusive thromboaortopathy (Takayasu's disease)","volume":"57","author":"Ishikawa","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF01744544","article-title":"Takayasu arteritis in Japan","volume":"7","author":"Koide","year":"1992","journal-title":"Heart Vessels Suppl"},{"issue":"Suppl.","key":"10.1016\/j.jjcc.2016.10.016_bib0180","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0167-5273(96)02813-6","article-title":"Angiographic findings of Takayasu arteritis: new classification","volume":"54","author":"Hata","year":"1996","journal-title":"Int J Cardiol"},{"issue":"Suppl.","key":"10.1016\/j.jjcc.2016.10.016_bib0185","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0167-5273(96)88774-2","article-title":"Comprehensive analysis of HLA genes in Takayasu arteritis in Japan","volume":"54","author":"Kimura","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium- and large-vessel vasculitis","volume":"349","author":"Weyand","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0195","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1253\/circj.CJ-12-0089","article-title":"New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis","volume":"76","author":"Takamura","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajhg.2013.05.024","article-title":"Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population","volume":"93","author":"Terao","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0205","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1253\/circj.CJ-11-1108","article-title":"Improved prognosis of Takayasu arteritis over the past decade \u2013 comprehensive analysis of 106 patients","volume":"76","author":"Ohigashi","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.1780370420","article-title":"Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate","volume":"37","author":"Hoffman","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0215","first-page":"1793","article-title":"Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis","volume":"30","author":"Valsakumar","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0220","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0225","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/ard.2008.093260","article-title":"Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up","volume":"67","author":"Molloy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0230","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ker380","article-title":"Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study","volume":"51","author":"Mekinian","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0235","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcmg.2012.01.013","article-title":"Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences","volume":"5","author":"Tezuka","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jjcc.2016.10.016_bib0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.CIR.100.1.55","article-title":"Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?","volume":"100","author":"Noris","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","article-title":"Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0250","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.39037","article-title":"Th1 and Th17 cytokines drive inflammation in Takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2011.08.001","article-title":"Pathogenesis of Takayasu's arteritis: a 2011 update","volume":"11","author":"Arnaud","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0260","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.93.10.1788","article-title":"Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis","volume":"93","author":"Seko","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","article-title":"Tocilizumab: a novel therapy for patients with large-vessel vasculitis","volume":"51","author":"Salvarani","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.jjcc.2016.10.016_bib0270","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/art.23373","article-title":"Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody","volume":"58","author":"Nishimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0275","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"1","author":"Ma","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0285","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cyto.2015.04.011","article-title":"Infliximab and etanercept have distinct actions but similar effects on cytokine profiles in rheumatoid arthritis","volume":"75","author":"Takeshita","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0290","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00380-015-0661-5","article-title":"A novel susceptibility locus for Takayasu arteritis in the IL12B region can be a genetic marker of disease severity","volume":"31","author":"Matsumura","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jjcc.2016.10.016_bib0300","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/hmg\/ddt034","article-title":"Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis","volume":"22","author":"Johnston","year":"2013","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871630291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871630291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:57:41Z","timestamp":1760273861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450871630291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S091450871630291X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.10.016","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}